Lefluniclo Kit
Product Images NDC 72835-602

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lefluniclo (NDC 72835-602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by V2 Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inflatherm Packaging (Inflatherm Packaging)

Packaging label for Inflatherm, featuring Diclofenac Sodium Tablets, USP 75 mg (60 count), and Menthol USP 3%, Camphor USP 3% Roll-On Gel (3 oz). The label indicates Rx Only status and includes storage instructions to keep at 20°C to 25°C, avoiding excessive heat. Manufactured by V2 Pharma, LLC.*

FDA Label Image

Sore No More Packaging (Snmwarm3ozlabel)

The image shows a Sore No More Natural Pain Relieving Gel packaging label for warm therapy. It highlights active ingredients Menthol 3% and Camphor 3% for external analgesic use to relieve minor aches and pains. The label includes drug facts, usage directions, warnings, manufacturer details, and a barcode.*

FDA Label Image

1 (Image 1)

Chemical structure of the active ingredient in Lefluniclo, a combination of Leflunomide and Diclofenac Sodium Gel. The image shows a molecular diagram with chlorine atoms, a carboxylate group, sodium ion, and aromatic rings representing the chemical makeup of the compound.*

FDA Label Image

1 (Image 2)

Lefluniclo kit packaging showing the proprietary name Lefluniclo. It contains Leflunomide and Diclofenac Sodium Gel as active ingredients. The product is labeled as a human prescription drug by V2 Pharma, LLC with product NDC 72835-602. The kit appears in a box format with a white and colored design displaying the product information.*

FDA Label Image

1 (Image 3)

Lefluniclo kit packaging showing the proprietary name Lefluniclo with the generic components Leflunomide and Diclofenac Sodium Gel. The label includes the product type as a human prescription drug and is distributed by V2 Pharma, LLC. The packaging is white with red and gray text accents, presenting a clean and professional design.*

FDA Label Image

2 (Image 5)

Label for Diclofenac Sodium Delayed-Release Tablets, USP 75 mg by Actavis. The rectangular label indicates 60 enteric-coated tablets, includes dosage information, storage instructions, manufacturer Actavis Elizabeth LLC in New Jersey, and distributor Actavis Pharma, Inc. The label is primarily white with teal accents and features a barcode and tablet image marked '551'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.